Provenance du réseau au premier degré de Mark Sampson
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 16 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mark Sampson via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
UBS | Investment Managers | Corporate Officer/Principal | |
CANACCORD GENUITY GROUP INC. | Investment Banks/Brokers | Corporate Officer/Principal | |
VECTURA GROUP | Pharmaceuticals: Major | Corporate Officer/Principal | |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Director/Board Member | |
Trigemina, Inc.
Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA. | Pharmaceuticals: Major | Director/Board Member | |
E-THERAPEUTICS PLC | Biotechnology | Director of Finance/CFO | |
COPENHAGEN CAPITAL A/S | Real Estate Development | Director/Board Member | |
SUN PHARMACEUTICAL INDUSTRIES LTD. | Pharmaceuticals: Major | Director/Board Member | |
GENMAB A/S | Pharmaceuticals: Major | Director/Board Member | |
OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member Director of Finance/CFO | |
BIOTEST AG | Pharmaceuticals: Other | Chairman | |
STADIUM GROUP LTD | Electronic Production Equipment | Director of Finance/CFO | |
CONROY GOLD AND NATURAL RESOURCES PLC | Precious Metals | Director/Board Member | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
University of Cambridge | College/University | Doctorate Degree | |
PHARMING GROUP N.V. | Pharmaceuticals: Major | Director of Finance/CFO | |
Dresdner Kleinwort Benson Equity | Corporate Officer/Principal | ||
The University of North Carolina at Chapel Hill | College/University | Masters Business Admin | |
University College Dublin | College/University | Undergraduate Degree | |
Archimedes Pharma Ltd.
Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO | |
London Business School | College/University | Graduate Degree | |
Coopers & Lybrand (London)
Coopers & Lybrand (London) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., Coopers & Lybrand (London) is a British company that provides accounting services. The company is based in Edinburgh, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BPC Plasma, Inc.
BPC Plasma, Inc. Pharmaceuticals: MajorHealth Technology BPC Plasma, Inc. manufactures pharmaceutical products. It offers the hyper immunoglobulin Nabi-HB, a key product used in the prevention of hepatitis B. The company was established in 2007 and is headquartered in Boca Raton, FL. | Pharmaceuticals: Major | Chairman | |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Air Partner Consulting Ltd.
Air Partner Consulting Ltd. Financial ConglomeratesFinance Founded in 1986, Air Partner Consulting Ltd. is a subsidiary of Wheels Up Experience, Inc. and functions as an investment holding British company. The company is based in Gatwick, UK. | Financial Conglomerates | Director/Board Member | |
Medica Reporting Ltd.
Medica Reporting Ltd. Medical/Nursing ServicesHealth Services Medica Reporting Ltd. provides radiology reporting services. It offers clinical services, including an on demand flexible radiology reporting service, seamless integration to in-house systems, emergency reporting services, multiple modalities and sub-specialties, and Web based report delivery to referrers. The company also provides technology offerings, such as DICOM storage solutions, picture archiving and communication systems, radiology information systems, remote reporting systems and tools, Web electronic patient record and results reporting solutions, purchase order and invoice processing systems, and project management and implementation services. Medica Reporting was founded in 2004 and is headquartered in Hastings, the United Kingdom. | Medical/Nursing Services | Director of Finance/CFO | |
Singer Capital Markets Securities Ltd.
Singer Capital Markets Securities Ltd. Investment Banks/BrokersFinance Part of N1 Singer Ltd., Singer Capital Markets Securities Ltd. is a brokerage firm. The company is based in London, UK. The British company was founded in 2012 by Timothy Bruce Cockroft, Peter Welch. Timothy Bruce Cockroft has been the CEO since 2012. | Investment Banks/Brokers | Analyst-Equity | |
PARATEK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
EUSA Pharma (UK) Ltd.
EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Medical Distributors | Director/Board Member | |
Shield TX (UK) Ltd.
Shield TX (UK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Shield Therapeutics Plc, Shield TX (UK) Ltd. is a British pharmaceutical company founded in 2008. The company is based in Gateshead, UK. Shield TX (UK specializes in developing innovative specialty pharmaceuticals to address significant unmet needs in the treatment of iron deficiency. The company's clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make the difference in their everyday lives. Visitors can browse their library of results, reports, and presentations on their website and sign up for investor news alerts. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MEDICA GROUP PLC | Medical/Nursing Services | Director of Finance/CFO | |
Ferring Holding, Inc.
Ferring Holding, Inc. Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, Ferring Holding, Inc. is a company that manufactures and sells pharmaceuticals. The company is based in Parsippany, NJ. | Pharmaceuticals: Major | Director/Board Member | |
NavBio AG
NavBio AG Miscellaneous Commercial ServicesCommercial Services NavBio AG provides business and management consulting services. | Miscellaneous Commercial Services | Director/Board Member | |
NUFORMIX PLC | Biotechnology | Director/Board Member | |
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Trizell Ltd. engages in research and experimental development on biotechnology. The company was founded on April 14, 1997 and is headquartered in Chinnor, the United Kingdom. | Biotechnology | Director/Board Member | |
Hox Therapeutics Ltd.
Hox Therapeutics Ltd. BiotechnologyHealth Technology Hox Therapeutics Ltd. develops therapeutics for cancer diseases based on the role of HOX genes. The private company is based in Guildford, UK. | Biotechnology | Chief Executive Officer | |
Mereo BioPharma 4 Ltd.
Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 4 Ltd. is a British biotechnology company founded in 2017 that provides research and development services. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Idt Biologika Corp. | Director/Board Member | ||
Novai Ltd.
Novai Ltd. Miscellaneous Commercial ServicesCommercial Services Novai Ltd. operates as a biotechnology company. It offers gene therapies, clinical research, optimize drug development services. The company was founded by Maria Francesca Cordeiro on February 12, 2020 and is headquartered in Reading, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Semdor Pharma Group GmbH
Semdor Pharma Group GmbH Pharmaceuticals: MajorHealth Technology Semdor Pharma Group GmbH is a German pharmaceutical company that specializes in narcotics and medical cannabis. With the merger of Cannamedical Pharma and PS Pharma, it is the only full-service pharmaceutical narcotics company in Germany that has its own medical cannabis brand and sales team. Semdor Pharma Group is the leading pharmaceutical company for narcotics and medical cannabis in Germany. | Pharmaceuticals: Major | Director/Board Member | |
Trizell Holding SA | Director/Board Member | ||
Dessau-Rosslau | Real Estate Development | Director/Board Member | |
JCA Seminars Ltd.
JCA Seminars Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Medica Group Plc, JCA Seminars Ltd. is a medical training company based in Hastings, UK. The British company offers worldwide radiology and medical CPD training in various specialist fields such as gynae, breast, cardiac CT, MRI, and paediatrics. The company welcomes sponsors from different backgrounds and specialities such as Phantoms, Ultrasound Equipment, and Recruitment agencies. JCA Seminars emphasizes the importance of bowel cancer screening in detecting bowel cancer at an early stage. The company was founded in 2003 by Jane Elizabeth Chandler, who has been the CEO since then. JCA Seminars was acquired by Medica Group Plc on March 29, 2023 for $1.73 million. | Miscellaneous Commercial Services | Director/Board Member | |
IDT Biologika GmbH
IDT Biologika GmbH Pharmaceuticals: MajorHealth Technology IDT Biologika GmbH manufactures and distributes vaccines and biopharmaceuticals for the protection of human and animal health. The firm offers development services and manufacturing facilities for clinical phase I to III as well as commercial supplies for viral and bacterial human and animal health vaccines. The company was founded on July 1, 1921 and is headquartered in Dessau-Rosslau, Germany. | Pharmaceuticals: Major | Director/Board Member | |
World Anti-Doping Agency | Director/Board Member |
Statistiques
Internationale
Royaume-Uni | 25 |
Etats-Unis | 11 |
Allemagne | 5 |
Suisse | 4 |
Canada | 3 |
Sectorielle
Health Technology | 22 |
Finance | 9 |
Commercial Services | 8 |
Consumer Services | 5 |
Distribution Services | 3 |
Opérationnelle
Director/Board Member | 100 |
Director of Finance/CFO | 24 |
Corporate Officer/Principal | 23 |
Independent Dir/Board Member | 21 |
Chief Executive Officer | 16 |
Relations les plus connectées
Insiders | |
---|---|
Hans-Peter Hasler | 28 |
Rolf K. Hoffmann | 27 |
Andrew Heath | 20 |
James Karis | 20 |
Karl Keegan | 18 |
Tim Watts | 17 |
Richard Jones | 15 |
Peter Llewellyn-Davies | 14 |
Angela Hildreth | 8 |
Joanne Elizabeth Estell | 7 |
Paul Spoors | 2 |
Paul Steckler | 2 |
Karen Nugent | 1 |
Kate Hopkinson | 1 |
Lucy Huntington-Bailey | 1 |
- Bourse
- Insiders
- Mark Sampson
- Connexions Sociétés